Baxter International, Inc.
This article was originally published in The Gray Sheet
Directors for upcoming cardiovascular device business spin-off in mid-2000 includes Michael Mussallem, who will be CEO and chairman of the new company. He has served as a group VP at Baxter since 1994. Also joining the board are Vernon Loucks, Baxter's current chairman, Avery Dennison Corp. President and CEO Philip Neal, and David Pyott, President and CEO of Allergan, Inc. The new company will have annual sales of approximately $900 mil
You may also be interested in...
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.
Rosa DeLauro prevails over fellow Democrats Debbie Wasserman Schultz and Marcy Kaptur for Appropriations chair. Frank Pallone gets unanimous support from Democrats to continue as Energy and Commerce chair.